The rise of cellular agriculture in India is redefining the future of food. From cultivated chicken and fish to ...

Andelyn Bio & Amplo Biotech partner to manufacture novel gene therapies for diseases affecting the neuromuscular junction: Columbus, Ohio Saturday, August 23, 2025, 10:00 Hrs [IST ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the most promising future stocks according to Wall Street analysts.

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common ...

RALEIGH, N.C. (WTVD) -- With so much uncertainty in the job market, along with concerns about funding for higher education, ...

A Cambridge biomedical research institute that launched last year with a roughly $600 million venture capital investment has ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $209.8, a high estimate of $240.00, and a low estimate of $166.00. A negative shift in sentiment ...

I maintain a Strong Buy on Krystal Biotech, as the pause in melanoma trial enrollment is offset by promising progress in ...

TC BioPharm CEO Bryan Kobel's service dog was seen plummeting to the pavement during a violent Uber driver attack in April.

No doubt, Nigerian scientists are making global contributions in various fields of science and technology. They have ...

NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.

Windtree Therapeutics plunges 77% after Nasdaq delisting notice, raising questions about its BNB treasury strategy and future ...